Simulations Plus to Participate in Upcoming Investor Conferences
Simulations Plus, Inc. (Nasdaq: SLP) (Simulations Plus, SLP), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced that Shawn...